AAAAAA

   
Results: 1-7 |
Results: 7
EVOLUTION OF HIV DRUG-RESISTANCE IN ZIDOVUDINE ZALCITABINE-EXPERIENCED AND ZIDOVUDINE/DIDANOSINE-EXPERIENCED PATIENTS RECEIVING LAMIVUDINE-CONTAINING COMBINATION THERAPY/
Authors: SCHMIT JC MARTINEZPICADO J RUIZ L TURAL C VANLAETHEM K CABRERA C IBANEZ A PUIG T WITVROUW M DESMYTER J DECLERCQ E CLOTET B VANDAMME AM
Citation: Jc. Schmit et al., EVOLUTION OF HIV DRUG-RESISTANCE IN ZIDOVUDINE ZALCITABINE-EXPERIENCED AND ZIDOVUDINE/DIDANOSINE-EXPERIENCED PATIENTS RECEIVING LAMIVUDINE-CONTAINING COMBINATION THERAPY/, Antiviral therapy, 3(2), 1998, pp. 81-88
EFFICACY OF ADDING INDINAVIR TO PREVIOUS REVERSE-TRANSCRIPTASE NUCLEOSIDE ANALOGS IN RELATION TO GENOTYPIC AND PHENOTYPIC RESISTANCE DEVELOPMENT IN ADVANCED HIV-1-INFECTED PATIENTS
Authors: RUIZ L NIJHUIS M BOUCHER C PUIG T BONJOCH A MARTINEZPICADO J MARFIL S DEJONG D BURGER D ARNO A BALAGUE M CLOTET B
Citation: L. Ruiz et al., EFFICACY OF ADDING INDINAVIR TO PREVIOUS REVERSE-TRANSCRIPTASE NUCLEOSIDE ANALOGS IN RELATION TO GENOTYPIC AND PHENOTYPIC RESISTANCE DEVELOPMENT IN ADVANCED HIV-1-INFECTED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 19(1), 1998, pp. 19-28
EFFICACY OF TRIPLE COMBINATION THERAPY WITH ZIDOVUDINE (ZDV) PLUS ZALCITABINE (DDC) PLUS LAMIVUDINE (3TC) VERSUS DOUBLE (ZDV+3TC) COMBINATION THERAPY IN PATIENTS PREVIOUSLY TREATED WITH ZDV+DDC
Authors: RUIZ L ROMEU J MARTINEZPICADO J SCHMIT JC VANDAMME AM BALAGUE M CABRERA C PUIG T TURAL C SEGURA A SIRERA G DECLERCQ E CLOTET B
Citation: L. Ruiz et al., EFFICACY OF TRIPLE COMBINATION THERAPY WITH ZIDOVUDINE (ZDV) PLUS ZALCITABINE (DDC) PLUS LAMIVUDINE (3TC) VERSUS DOUBLE (ZDV+3TC) COMBINATION THERAPY IN PATIENTS PREVIOUSLY TREATED WITH ZDV+DDC, AIDS, 10(14), 1996, pp. 61-66
QUANTITATIVE HIV-1 RNA AS A MARKER OF CLINICAL STABILITY AND SURVIVALIN A COHORT OF 302 PATIENTS WITH A MEAN CD4 CELL COUNT OF 300X10(6) L/
Authors: RUIZ L ROMEU J CLOTET B BALAGUE M CABRERA C SIRERA G IBANEZ A MARTINEZPICADO J RAVENTOS A TURAL C SEGURA A FOZ M
Citation: L. Ruiz et al., QUANTITATIVE HIV-1 RNA AS A MARKER OF CLINICAL STABILITY AND SURVIVALIN A COHORT OF 302 PATIENTS WITH A MEAN CD4 CELL COUNT OF 300X10(6) L/, AIDS, 10(11), 1996, pp. 39-44
SPECIES-SPECIFIC DETECTION OF VIBRIO-ANGUILLARUM IN MARINE AQUACULTURE ENVIRONMENTS BY SELECTIVE CULTURE AND DNA HYBRIDIZATION
Authors: MARTINEZPICADO J ALSINA M BLANCH AR CERDA M JOFRE J
Citation: J. Martinezpicado et al., SPECIES-SPECIFIC DETECTION OF VIBRIO-ANGUILLARUM IN MARINE AQUACULTURE ENVIRONMENTS BY SELECTIVE CULTURE AND DNA HYBRIDIZATION, Applied and environmental microbiology, 62(2), 1996, pp. 443-449
A MEDIUM FOR PRESUMPTIVE IDENTIFICATION OF VIBRIO-ANGUILLARUM
Authors: ALSINA M MARTINEZPICADO J JOFRE J BLANCH AR
Citation: M. Alsina et al., A MEDIUM FOR PRESUMPTIVE IDENTIFICATION OF VIBRIO-ANGUILLARUM, Applied and environmental microbiology, 60(5), 1994, pp. 1681-1683
RAPID DETECTION AND IDENTIFICATION OF VIBRIO-ANGUILLARUM BY USING SPECIFIC OLIGONUCLEOTIDE PROBE COMPLEMENTARY TO 16S RIBOSOMAL-RNA
Authors: MARTINEZPICADO J BLANCH AR JOFRE J
Citation: J. Martinezpicado et al., RAPID DETECTION AND IDENTIFICATION OF VIBRIO-ANGUILLARUM BY USING SPECIFIC OLIGONUCLEOTIDE PROBE COMPLEMENTARY TO 16S RIBOSOMAL-RNA, Applied and environmental microbiology, 60(2), 1994, pp. 732-737
Risultati: 1-7 |